These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16160628)

  • 1. Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine-maintained than in methadone-maintained patients: results of a randomized clinical trial.
    Soyka M; Hock B; Kagerer S; Lehnert R; Limmer C; Kuefner H
    J Clin Psychopharmacol; 2005 Oct; 25(5):490-3. PubMed ID: 16160628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of long-term maintenance treatment with buprenorphine on complex psychomotor and cognitive function.
    Shmygalev S; Damm M; Weckbecker K; Berghaus G; Petzke F; Sabatowski R
    Drug Alcohol Depend; 2011 Sep; 117(2-3):190-7. PubMed ID: 21353749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial.
    Soyka M; Lieb M; Kagerer S; Zingg C; Koller G; Lehnert P; Limmer C; Kuefner H; Hennig-Fast K
    J Clin Psychopharmacol; 2008 Dec; 28(6):699-703. PubMed ID: 19011441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Less driving impairment on buprenorphine than methadone in drug-dependent patients?
    Soyka M; Horak M; Dittert S; Kagerer S
    J Neuropsychiatry Clin Neurosci; 2001; 13(4):527-8. PubMed ID: 11748323
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of peak and trough levels of opioid maintenance therapy on driving aptitude.
    Baewert A; Gombas W; Schindler SD; Peternell-Moelzer A; Eder H; Jagsch R; Fischer G
    Eur Addict Res; 2007; 13(3):127-35. PubMed ID: 17570908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
    Loeber S; Kniest A; Diehl A; Mann K; Croissant B
    Am J Drug Alcohol Abuse; 2008; 34(5):584-93. PubMed ID: 18720267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical trial on the acute effects of methadone and buprenorphine on actual driving and cognitive function of healthy volunteers.
    Strand MC; Vindenes V; Gjerde H; Mørland JG; Ramaekers JG
    Br J Clin Pharmacol; 2019 Feb; 85(2):442-453. PubMed ID: 30515857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can patients receiving opioid maintenance therapy safely drive? A systematic review of epidemiological and experimental studies on driving ability with a focus on concomitant methadone or buprenorphine administration.
    Strand MC; Fjeld B; Arnestad M; Mørland J
    Traffic Inj Prev; 2013; 14(1):26-38. PubMed ID: 23259516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of cognitive function in patients under maintenance treatment with heroin, methadone, or buprenorphine and healthy controls: an open pilot study.
    Soyka M; Limmer C; Lehnert R; Koller G; Martin G; Küfner H; Kagerer S; Haberthür A
    Am J Drug Alcohol Abuse; 2011 Nov; 37(6):497-508. PubMed ID: 21851203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates.
    Rapeli P; Fabritius C; Kalska H; Alho H
    BMC Clin Pharmacol; 2011 Aug; 11():13. PubMed ID: 21854644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls.
    Rapeli P; Fabritius C; Alho H; Salaspuro M; Wahlbeck K; Kalska H
    BMC Clin Pharmacol; 2007 Jun; 7():5. PubMed ID: 17565668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do drug treatment variables predict cognitive performance in multidrug-treated opioid-dependent patients? A regression analysis study.
    Rapeli P; Fabritius C; Kalska H; Alho H
    Subst Abuse Treat Prev Policy; 2012 Nov; 7():45. PubMed ID: 23121989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive-motor performance of methadone-maintained patients.
    Specka M; Finkbeiner T; Lodemann E; Leifert K; Kluwig J; Gastpar M
    Eur Addict Res; 2000 Mar; 6(1):8-19. PubMed ID: 10729738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing cognitive and psychomotor performance under long-term treatment with transdermal buprenorphine in chronic noncancer pain patients.
    Dagtekin O; Gerbershagen HJ; Wagner W; Petzke F; Radbruch L; Sabatowski R
    Anesth Analg; 2007 Nov; 105(5):1442-8, table of contents. PubMed ID: 17959980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance therapy with synthetic opioids and driving aptitude.
    Schindler SD; Ortner R; Peternell A; Eder H; Opgenoorth E; Fischer G
    Eur Addict Res; 2004; 10(2):80-7. PubMed ID: 15004452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.
    Ling W; Wesson DR; Charuvastra C; Klett CJ
    Arch Gen Psychiatry; 1996 May; 53(5):401-7. PubMed ID: 8624183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dose-effect study of repeated administration of buprenorphine/naloxone on performance in opioid-dependent volunteers.
    Mintzer MZ; Correia CJ; Strain EC
    Drug Alcohol Depend; 2004 May; 74(2):205-9. PubMed ID: 15099664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of Single Doses of Methadone and Buprenorphine in Blood and Oral Fluid in Healthy Volunteers and Correlation With Effects on Psychomotor and Cognitive Functions.
    Strand MC; Ramaekers JG; Gjerde H; Mørland J; Vindenes V
    J Clin Psychopharmacol; 2019; 39(5):489-493. PubMed ID: 31305338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent.
    Compton P; Charuvastra VC; Ling W
    Drug Alcohol Depend; 2001 Jul; 63(2):139-46. PubMed ID: 11376918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mother-child interaction and cognitive development in children prenatally exposed to methadone or buprenorphine.
    Konijnenberg C; Sarfi M; Melinder A
    Early Hum Dev; 2016 Oct; 101():91-7. PubMed ID: 27614330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.